MWNA
APEN

Marshall Wace North America’s Apollo Endosurgery, Inc. APEN Stock Holding History

Marshall Wace North America’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$147K Sell
16,203
-3,259
-17% -$28K ﹤0.01% 1343
2021
Q2 		$158K Buy
19,462
+5,914
+44% +$40.6K ﹤0.01% 1369
2021
Q1 		$75K Buy
+13,548
New +$67K ﹤0.01% 1448

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace North America's APEN Position: Q3 2021 in Review

Marshall Wace North America reduced its Apollo Endosurgery, Inc. (APEN) stake by 17% in Q3 2021, selling an estimated $28K and leaving 16,203 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1343.

Marshall Wace North America first reported a position in APEN in Q1 2021 and has held it in 3 quarters since. The position peaked at $158K in Q2 2021. 55 funds tracked by Wall St. Rank hold APEN as of Q3 2021.

  • Marshall Wace North America held 16,203 shares of Apollo Endosurgery, Inc. worth $147K as of Q3 2021.
  • Marshall Wace North America sold 3,259 Apollo Endosurgery, Inc. shares in Q3 2021, an estimated $28K.
  • Apollo Endosurgery, Inc. made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1343 holding.
  • Marshall Wace North America first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and has held it in 3 quarters since.
  • Marshall Wace North America's Apollo Endosurgery, Inc. position peaked at $158K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.